jaleo_leo Profile Banner
Javier Leo Profile
Javier Leo

@jaleo_leo

Followers
48
Following
392
Media
15
Statuses
121

PhD student MD Anderson | Prostate cancer research

Texas, USA
Joined August 2021
Don't wanna be here? Send us removal request.
@ScientificEhsan
Shafqat Ehsan 👨‍🔬🧬
1 year
Professor Leo 🫡🫡🫡
@jaleo_leo
Javier Leo
1 year
I had the opportunity to teach summer students about the cell cycle today. It was an amazing time🥳
0
1
4
@jaleo_leo
Javier Leo
1 year
I had the opportunity to teach summer students about the cell cycle today. It was an amazing time🥳
1
0
6
@MDA_UTHGrad
MD Anderson-UTH Grad
2 years
The 2023-2024 Oates Family GSBS Endowment Scholarship recipient is Javier Leo! Leo is with the Cancer Biology program & his advisor is Di Zhao, PhD. #WeAreGSBS #GSBS60
0
2
15
@TheFigen_
The Figen
2 years
Happy International Women's Day! 🥳🥳 #WomensDay
2K
57K
290K
@ED_PhD_
Eleonora Dondossola,PhD
2 years
🚨🚨🚨 Twittorial 🚨🚨🚨 #Cancer-#bone cell interplays have emerged as driver of disease progression & therapy resistance. 👉To best understand these central interactions, biologically relevant #preclinical models are needed 1/n
6
4
23
@PCFnews
Prostate Cancer Foundation
2 years
The PCF Women in Science Forum aims to build a strong network of women in prostate cancer research and address gender inequities in science. Dr @vedangiri, Dr. @AyeshaShafi_PhD, & Dr. @Fletcher_C discuss the importance of this initiative on @urotoday https://t.co/qY26ErYVtO
0
6
27
@jaleo_leo
Javier Leo
2 years
Very informative session! I’m even more excited to uncover and dissect mechanisms of AR resistance.
@DanielFrigo
Daniel E. Frigo, Ph.D.
2 years
Despite what you may have heard, the #androgenreceptor is still a big deal in #prostatecancer. But how we target AR is evolving. Join us Jan 16 for a free @TheEndoSociety webinar with an expert panel to discuss new trends in anti-AR therapy. Registration👉 https://t.co/4MAtiuunk7
0
0
4
@DanielFrigo
Daniel E. Frigo, Ph.D.
2 years
Despite what you may have heard, the #androgenreceptor is still a big deal in #prostatecancer. But how we target AR is evolving. Join us Jan 16 for a free @TheEndoSociety webinar with an expert panel to discuss new trends in anti-AR therapy. Registration👉 https://t.co/4MAtiuunk7
1
16
45
@jaleo_leo
Javier Leo
2 years
“Why a PhD?” Ummm that’s a mystery we are trying to solve❔🔎
0
0
5
@ChackLab
Bryce Chackerian
2 years
Our most recent publication in npj vaccines (@Nature_NPJ) describes a vaccine against PCSK9 that lowers LDL cholesterol levels in mice and non-human primates
Tweet card summary image
nature.com
npj Vaccines - A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primates
1
3
17
@PCFnews
Prostate Cancer Foundation
2 years
The @US_FDA has approved a new medication, niraparib, in combination with abiraterone acetate for patients with metastatic castration-resistant prostate cancer (mCRPC) who also have mutations in specific genes called BRCA1 and BRCA2. https://t.co/dEBbWyy8cM
0
4
10
@MichaelGBertram
Michael Bertram
2 years
Exciting to see our introductory guide to #OpenScience published today in @CurrentBiology! 🥳 Hopefully, this will be a useful resource for newcomers to open science, including by providing a handy list of tools and resources! Read it #OpenAccess 👉 https://t.co/5wmDU2s8gW
1
41
101
@ThePhDPlace
The PhD Place
2 years
Thinking about doing a PhD vs actually doing a PhD
40
923
6K
@NatlParkService
National Park Service
2 years
Maybe she's born with it, maybe it's neighbelline.
270
3K
31K
@Cancer_Cell
Cancer Cell
2 years
Online Now: Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer
1
4
26
@ivancalcantara
Ivan Alcantara
2 years
I’m currently in my PhD program and I don’t go to parties AT ALL, and I’m still not successful
@salesses
the writer formerly known as Matthew Salesses
2 years
When I was in my PhD program I didn’t go to any parties except one, where a bunch of the other students cornered me, drunk, to ask what I was doing that I was getting some success, as if it wasn’t just from writing instead of going to parties and watching too much tv.
10
43
979
@xingxing_zang
XingXing Zang
2 years
The ability of CD4+ effector cells to contribute to antitumour immunity independently of CD8+ T cells is increasingly recognized. CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours
1
8
43
@TinaLasisi
Tina Lasisi, PhD
2 years
1/8 🧵 Fresh off the press! 📰 Our paper “Human scalp hair as a thermoregulatory adaptation” just got published in PNAS. 🎉 Here’s the summary in a thread…
22
240
923
@DanielFrigo
Daniel E. Frigo, Ph.D.
3 years
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
The androgen receptor (AR) is one of the oldest therapeutic targets in oncology and continues to dominate the treatment landscape for advanced prostate cancer, where nearly all treatment regimens...
@OncHahn
Andy Hahn
3 years
Check out our review on AR in non-cancer cells, https://t.co/HNjkyTxITR, including the immune system, fibroblasts, bone, adipocytes and CV in @TheEndoSociety Learned a lot from co-authors on the complicated role of AR signaling in these compartments. @DanielFrigo led this effort!
0
5
28